Importantly, Myct1 inhibition (i.e., Myct1 global knockout and Myct1 endothelial knockout) led to a reduction in tumor growth and angiogenesis, reminiscent of Etv2-deficient tumor vessel [61]. This evidence concerns the gene ETV2 and neoplasm.